Works matching DE "PHOSPHODIESTERASE inhibitors"

Results: 1545

Atopic Dermatitis: clinical aspects and treatments.

Published in:

World Council of Enterostomal Therapists Journal, 2024, v. 44, n. 2, p. 29, doi. 10.33235/wcet.44.2.29-36

By:

Geng, Ryan S. Q.;
Sibbald, R. Gary

Publication type:

Article

Studies highlight costs, risks with direct-to-consumer men's health products.

Published in:

Urology Times, 2021, v. 49, n. 10, p. 36

By:

SAYLOR, BENJAMIN P.

Publication type:

Article

Expert pointers on BPH evaluation and treatment... Alexis E. Te.

Published in:

2021

By:

Badlani, Gopal H.

Publication type:

Interview

Increased shockwave therapy sessions linked to enhanced benefit for ED.

Published in:

Urology Times, 2020, v. 48, n. 10, p. 15

By:

Broderick, Jason M.

Publication type:

Article

No link between PDE-5 use, prostate Ca recurrence.

Published in:

Urology Times, 2016, v. 44, n. 6, p. 13

By:

Kuznar, Wayne

Publication type:

Article

ED, diabetes, and CV risk: Update on treatment, risk reduction.

Published in:

Urology Times, 2016, v. 44, n. 1, p. 15

By:

Walker, Charles;
Suarez-Sarmiento, Alfredo

Publication type:

Article

Shock wave therapy found efficacious in treating ED.

Published in:

Urology Times, 2015, v. 43, n. 11, p. 8

By:

Guttman Krader, Cheryl

Publication type:

Article

IN THE PUBLIC EYE.

Published in:: Urology Times, 2015, v. 43, n. 9, p. 44
Publication type:: Article

Data confirm quick erectogenic effect of ED agent.

Published in:

Urology Times, 2015, v. 43, n. 1, p. 18

By:

Krader, Cheryl Guttman

Publication type:

Article

Clinical Updates. FDA approves NDA for fast-acting PDE-5 inhibitor.

Published in:: Urology Times, 2014, v. 42, n. 11, p. 10
Publication type:: Article

Many PDE-5 inhibitor non-responders could be taking medication incorrectly.

Published in:: Urology Times, 2014, v. 42, n. 8, p. 60
Publication type:: Article

PDE-5 use shows no effect on BPH therapy outcomes.

Published in:

Urology Times, 2012, v. 40, n. 12, p. 16

By:

Bankhead, Charles

Publication type:

Article

PDE-5, alpha-blocker each relieve LUTS/BPH symptoms.

Published in:

Urology Times, 2012, v. 40, n. 12, p. 21

By:

Bankhead, Charles

Publication type:

Article

OK to give PDE-5 Rx for pleasure only? Opinion split.

Published in:

Urology Times, 2012, v. 40, n. 7, p. 34

By:

Binder, Stefanie Petrou

Publication type:

Article

PDE-5 inhibitors found safe, efficacious for LUTS.

Published in:

Urology Times, 2012, v. 40, n. 7, p. 12

By:

Binder, Stefanie Petrou

Publication type:

Article

Large study bolsters efficacy, safety of long-acting TRT.

Published in:

Urology Times, 2012, v. 40, n. 3, p. 22

By:

Wirschubsky, Zvi Gregory

Publication type:

Article

PDE-5 inhibitor improves both ED, BPH symptoms.

Published in:

Urology Times, 2011, v. 39, n. 7, p. 10

By:

Wirschubsky, Zvi Gregory

Publication type:

Article

PDE-5s for LUTS: A story to tell or not?

Published in:

2011

By:

Kaplan, Steven A.

Publication type:

Opinion

PE: Is an ideal therapy on the horizon?

Published in:

2010

By:

MuIcahy, John J.

Publication type:

Opinion

New frontiers in medical management of BPH.

Published in:

Urology Times, 2010, v. 38, n. 1, p. 26

By:

Lepor, Herbert

Publication type:

Article

ACP guideline supports use of PDE-5 inhibitors for ED.

Published in:: Urology Times, 2009, v. 37, n. 13, p. 6
Publication type:: Article

A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios.

Published in:

Journal of Computer-Aided Molecular Design, 2022, v. 36, n. 10, p. 753, doi. 10.1007/s10822-022-00478-x

By:

Tosstorff, Andreas;
Rudolph, Markus G.;
Cole, Jason C.;
Reutlinger, Michael;
Kramer, Christian;
Schaffhauser, Hervé;
Nilly, Agnès;
Flohr, Alexander;
Kuhn, Bernd

Publication type:

Article

Effect of Sildenafil on Pressure-Volume Loop Measures of Ventricular Function in Fontan Patients.

Published in:

Pediatric Cardiology, 2016, v. 37, n. 1, p. 184, doi. 10.1007/s00246-015-1262-x

By:

Butts, Ryan;
Chowdhury, Shahryar;
Baker, George;
Bandisode, Varsha;
Savage, Andrew;
Atz, Andrew

Publication type:

Article

Evolving Management of Pediatric Pulmonary Arterial Hypertension: Impact of Phosphodiesterase Inhibitors.

Published in:

Pediatric Cardiology, 2013, v. 34, n. 2, p. 213, doi. 10.1007/s00246-012-0598-8

By:

Wardle, Andrew;
Tulloh, Robert

Publication type:

Article

The effect of BI 409306 on heart rate in healthy volunteers: a randomised, double-blind, placebo-controlled, crossover study.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 801, doi. 10.1007/s00228-022-03274-6

By:

Müller, Fabian;
Sand, Michael;
Wunderlich, Glen;
Link, Jasmin;
Schultheis, Christian;
Dansirikul, Chantaratsamon;
Sane, Rucha;
Laszlo, Roman;
Steinacker, Jürgen M.

Publication type:

Article

Impact of biological therapy on spondyloarthritis.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 9, p. 1021, doi. 10.1007/s00228-014-1706-x

By:

Maruotti, Nicola;
Cantatore, Francesco

Publication type:

Article

Nonsteroidal Topical Treatments for Eczema: A Product Snapshot with Mona Shahriari, MD: They are a Janus kinase (JAK)1/JAK2 inhibitor, a phosphodiesterase-4 inhibitor, and an investigational aryl hydrocarbon receptor agonist. Learn more about each.

Published in:

Patient Care (Online), 2024, p. 1

By:

Halsey, Grace

Publication type:

Article

New Drug Boosts COPD Lung Function, QoL Regardless of Severity: Daily Dose.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

Proniosomal Gel-Loaded Phosphodiesterase Inhibitors (Sildenafil, Vardenafil, and Tadalafil): Prospects for Topical Penile Therapy of Tadalafil for Treatment of Erectile Dysfunction.

Published in:

Gels (2310-2861), 2023, v. 9, n. 8, p. 597, doi. 10.3390/gels9080597

By:

Mohamed, Soad A.;
Rofaeil, Remon Roshdy;
Salem, Hesham;
Elrehany, Mahmoud;
Asiri, Yahya I.;
Al Fatease, Adel;
Abdelkader, Hamdy

Publication type:

Article

Trial of a preferential phosphodiesterase 4B inhibitor for idiopathic pulmonary fibrosis.

Published in:

African Journal of Thoracic & Critcal Care Medicine, 2022, v. 28, n. 3, p. 135

By:

Seedat, U. F.

Publication type:

Article

PROBLEMÁTICA DA AUTOMEDICAÇÃO COM INIBIDORES DA FOSFODIESTERASE 5 UMA ABORDAGEM FARMACÊUTICA.

Published in:

Revista Foco (Interdisciplinary Studies Journal), 2024, v. 17, n. 11, p. 1, doi. 10.54751/revistafoco.v17n11-255

By:

Macêdo da Silva, Joane Cristina;
Martins Pontes, Kaio Vinicius;
Borges Correa, Noelinelma;
Cunha da Costa, Valéria;
Lima da Silva, Weison;
Bento da Silva, Tallyson Menezes

Publication type:

Article

Repurposing of phosphodiesterase-5 inhibitor sildenafil as a therapeutic agent to prevent gastric cancer growth through suppressing c-MYC stability for IL-6 transcription.

Published in:

Communications Biology, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s42003-025-07519-9

By:

Zhang, Zhenzhan;
Huang, Wuqing;
Huang, Donghua;
Xu, Zhou;
Xie, Qingfeng;
Tan, Xin;
He, Wenjun;
Yang, Weihao;
Li, Guoxin;
Ji, Jianguang;
Liu, Hao

Publication type:

Article

Psoriasis: Systemic treatment options for adults.

Published in:

Medicine Today, 2024, v. 25, n. 9, p. 29

By:

DANIEL, BENJAMIN S.;
NGUYEN, JACQUELINE K.;
SHUMACK, STEPHEN;
FOLEY, PETER

Publication type:

Article

Managementul terapeutic al bolii pulmonare obstructive cronice.

Published in:

Farmacist.ro, 2019, n. 6, p. 6

By:

Marineci, Cristina Daniela;
Zanfirescu, Anca;
Chiriţă, Cornel

Publication type:

Article

Phosphodiesterase 4 Inhibition Impairs Cocaine-Induced Inhibitory Synaptic Plasticity and Conditioned Place Preference.

Published in:

Neuropsychopharmacology, 2012, v. 37, n. 11, p. 2377, doi. 10.1038/npp.2012.93

By:

Zhong, Peng;
Wang, Wei;
Yu, Fei;
Nazari, Maressa;
Liu, Xiaojie;
Liu, Qing-Song

Publication type:

Article

Retrospective Database Analysis of Treatment Patterns Among Patients with Pulmonary Arterial Hypertension.

Published in:

Pulmonary Therapy, 2020, v. 6, n. 1, p. 79, doi. 10.1007/s41030-019-00106-4

By:

Studer, Sean;
Hull, Michael;
Pruett, Janis;
Elliott, Caitlin;
Tsang, Yuen;
Drake, William

Publication type:

Article

Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics.

Published in:

Vaccines, 2021, v. 9, n. 2, p. 94, doi. 10.3390/vaccines9020094

By:

Mintz, Joel;
Vedenko, Anastasia;
Rosete, Omar;
Shah, Khushi;
Goldstein, Gabriella;
Hare, Joshua M.;
Ramasamy, Ranjith;
Arora, Himanshu;
Agarwal, Sumit

Publication type:

Article

DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.

Published in:

Tissue Barriers, 2020, v. 8, n. 3, p. 1, doi. 10.1080/21688370.2020.1765633

By:

Hunt, David W.C.;
Ivanova, Iordanka A.;
Dagnino, Lina

Publication type:

Article

FKBP38 过表达联合PDE4 抑制剂ZL-n-91 对肝细胞癌的抑制作用研究.

Published in:

Progress in Modern Biomedicine, 2025, v. 25, n. 2, p. 201, doi. 10.13241/j.cnki.pmb.2025.02.001

By:

王帅;
唐敏怡;
邢朝凤;
胡恩瑜;
曹洁琳;
李芳红;
赵子建

Publication type:

Article

Molecular docking and dynamics simulation analysis of PDE5 inhibitor candidates for erectile dysfunction treatment.

Published in:

European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 20, p. 4420

By:

AKDOGAN, N.;
RAWAT, R.;
OZDEN, T.;
UZAN, F.;
DEGER, M.;
YILMAZ, I. O.;
ATES, T.;
ARIDOGAN, I. A.

Publication type:

Article

Potential usefulness of pentoxifylline, a non-specific phosphodiesterase inhibitor with anti-inflammatory, anti-thrombotic, antioxidant, and anti-fibrogenic properties, in the treatment of SARS-CoV-2.

Published in:

European Review for Medical & Pharmacological Sciences, 2020, v. 24, n. 13, p. 7494

By:

GONZÁLEZ-PACHECO, H.;
AMEZCUA-GUERRA, L. M.;
SANDOVAL, J.;
ARIAS-MENDOZA, A.

Publication type:

Article

MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells.

Published in:

European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 10, p. 2004

By:

LI, L.;
XU, Q.-H.;
DONG, Y.-H.;
LI, G.-X.;
YANG, L.;
WANG, L.-W.;
LI, H.-Y.

Publication type:

Article

Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation database.

Published in:

International Journal of Urology, 2017, v. 24, n. 7, p. 518, doi. 10.1111/iju.13358

By:

Okihara, Koji;
Yorozu, Atsunori;
Saito, Shiro;
Tanaka, Nobumichi;
Koga, Hirofumi;
Higashide, Satoshi;
Kikuchi, Takashi;
Nakano, Masahiro

Publication type:

Article

Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3′,5′-monophosphate pathway.

Published in:

International Journal of Urology, 2017, v. 24, n. 6, p. 412, doi. 10.1111/iju.13336

By:

Higashi, Yukihito

Publication type:

Article

Editorial Comment to Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy.

Published in:

International Journal of Urology, 2013, v. 20, n. 4, p. 419, doi. 10.1111/j.1442-2042.2012.03163.x

By:

Gacci, Mauro

Publication type:

Article

Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy.

Published in:

International Journal of Urology, 2013, v. 20, n. 4, p. 413, doi. 10.1111/j.1442-2042.2012.03149.x

By:

Gandaglia, Giorgio;
Albersen, Maarten;
Suardi, Nazareno;
Gallina, Andrea;
Abdollah, Firas;
Castiglione, Fabio;
Capitanio, Umberto;
Salonia, Andrea;
Rigatti, Patrizio;
Hedlund, Petter;
Montorsi, Francesco;
Briganti, Alberto

Publication type:

Article

Optimization of sexual function outcome after radical prostatectomy using phosphodiesterase type 5 inhibitors.

Published in:

International Journal of Urology, 2013, v. 20, n. 3, p. 285, doi. 10.1111/iju.12071

By:

Kaiho, Yasuhiro;
Yamashita, Shinichi;
Arai, Yoichi

Publication type:

Article

Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A randomized placebo- and tamsulosin-controlled 12-week study in Asian men.

Published in:

International Journal of Urology, 2013, v. 20, n. 2, p. 193, doi. 10.1111/j.1442-2042.2012.03130.x

By:

Yokoyama, Osamu;
Yoshida, Masaki;
Kim, Sae Chul;
Wang, Chii‐Jye;
Imaoka, Takeshi;
Morisaki, Yoji;
Viktrup, Lars

Publication type:

Article

Common theme for drugs effective in overactive bladder treatment: Inhibition of afferent signaling from the bladder.

Published in:

International Journal of Urology, 2013, v. 20, n. 1, p. 21, doi. 10.1111/j.1442-2042.2012.03196.x

By:

Hood, Brandy;
Andersson, Karl‐Erik

Publication type:

Article

A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder.

Published in:

Brain Sciences (2076-3425), 2024, v. 14, n. 3, p. 294, doi. 10.3390/brainsci14030294

By:

Celik, Muhammet;
Gold, Mark S.;
Fuehrlein, Brian

Publication type:

Article